Drug Database
Back to search

Poland· PL-100378362

Glypvilo

A vildagliptin product containing vildagliptinum, registered in Poland by Krka, d.d., Novo mesto. The same ATC class is registered in 16 of our 19 countries.

ATC A10BH02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedGlypviloATCA10BH02REGISTER NO.PL-100378362PACKS LISTED7CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about vildagliptinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Vildagliptin is registered in 16 of 19 countries.

Countries holding a registration under ATC A10BH02 (vildagliptin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search vildagliptin products by name

Vildagliptin · ATC A10BH02

16 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of vildagliptin costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.32 in France to $1.98 in Switzerland — a ×6.2 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Vildagliptin · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.98
  • IT Italy$1.0
  • FR France$0.32
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Vildagliptinum
Manufacturer
Krka, d.d., Novo mesto
Country
Poland (PL)
ATC code
A10BH02
ATC class
Vildagliptin
Defined daily dose
0.1 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 7

1 priced
  • gtin
    05909991372385
    60 szt.
    PLN 40.76
  • gtin
    05909991372354
  • gtin
    05909991372361
  • gtin
    05909991372378
  • gtin
    05909991372392
  • gtin
    05909991372408
  • gtin
    05909991372415

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Vildagliptin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vildagliptin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Melkart, Saxotin
  • Belgium · Vildagliptin Krka
  • Bulgaria · Глипвило, Далмевин
  • Cyprus · Aglimon, Dalmevin
  • Czechia · Alikval, Anvildis
  • Germany · Vildabetes, Vildagliptin Al
  • Denmark · Vildagliptin "a. E. Tiefenbacher", Vildagliptin "axunio"
  • Estonia · Dalmevin, Glypvilo
  • Spain · Vildagliptina, Vildagliptina Alter
  • Finland · Vildagliptin Krka, Vildagliptin Ratiopharm
  • France · Vildagliptine Accord, Vildagliptine Arrow
  • United Kingdom (Northern Ireland) · Vildagliptin, Vildagliptin Accord-Uk
  • Greece · Dalmevin, Varbos
  • Croatia · Agnis, Dalmevin
  • Hungary · Agartha, Alikval
  • Ireland · Vildagliptin Krka
  • Iceland · Galvus, Jalra
  • Italy · Vildagliptin Accord, Vildagliptin Aurobindo
  • Liechtenstein · Galvus, Jalra
  • Lithuania · Dalmevin, Glypvilo
  • Latvia · Dalmevin, Glypvilo
  • Malta · Alikval, Dalmevin
  • Netherlands · Vilanov, Vildagliptine Accord
  • Norway · Galvus, Jalra
  • Portugal · Tutecvi, Vezagla
  • Romania · Agartha, Dalmevin
  • Sweden · Dalmevin, Kwikaton
  • Slovenia · Glypvilo
  • Slovakia · Anvildis, Dalmevin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7b562d73-a727-4043-b606-8b2837c40672
GET /v1/drugs/7b562d73-a727-4043-b606-8b2837c40672?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "50 mg",
  "packaging": "05909991372354 ¦ Rp ¦ 128150\n28 tabl.\n05909991372361 ¦ Rp ¦ 128151\n30 tabl.\n05909991372378 ¦ Rp ¦ 128152\n56 tabl.\n05909991372385 ¦ Rp ¦ 128153\n60 tabl.\n05909991372392 ¦ Rp ¦ 128154\n90 tabl.\n05909991372408 ¦ Rp ¦ 128155\n112 tabl.\n05909991372415 ¦ Rp ¦ 128156\n180 tabl.",
  "substance": "Vildagliptinum 50 mg",
  "common_name": "Vildagliptinum",
  "pl_product_id": "100378362",
  "pozwolenie_nr": "24758",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about vildagliptin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console